Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma

| April 1, 2015 | 0 Comments

A company that produces a cancer vaccine called CRS-207 has been granted orphan drug status for the treatment of malignant mesothelioma, potentially opening new treatment possibilities for patients with this rare cancer.

View original post here:
Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma

Tags: , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply